McKesson ROA 2010-2024 | MCK

Current and historical return on assets (ROA) values for McKesson (MCK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
McKesson ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $2.54B $72.43B 3.65%
2024-06-30 $2.96B $71.67B 4.36%
2024-03-31 $3.00B $67.44B 4.55%
2023-12-31 $3.00B $66.51B 4.63%
2023-09-30 $3.49B $66.09B 5.47%
2023-06-30 $3.75B $64.10B 5.95%
2023-03-31 $3.56B $62.32B 5.69%
2022-12-31 $3.14B $62.69B 5.00%
2022-09-30 $2.06B $63.08B 3.26%
2022-06-30 $1.40B $62.30B 2.21%
2022-03-31 $1.11B $63.30B 1.76%
2021-12-31 $1.41B $63.71B 2.21%
2021-09-30 $-4.81B $63.60B -7.59%
2021-06-30 $-4.50B $62.89B -7.16%
2021-03-31 $-4.54B $65.02B -7.38%
2020-12-31 $-4.18B $61.85B -6.91%
2020-09-30 $2.23B $61.56B 3.69%
2020-06-30 $0.92B $57.67B 1.54%
2020-03-31 $0.90B $61.25B 1.48%
2019-12-31 $-0.92B $60.87B -1.52%
2019-09-30 $-0.63B $58.99B -1.05%
2019-06-30 $0.60B $61.68B 0.98%
2019-03-31 $0.03B $59.67B 0.06%
2018-12-31 $-0.32B $61.01B -0.52%
2018-09-30 $0.12B $61.42B 0.19%
2018-06-30 $-0.38B $61.28B -0.61%
2018-03-31 $0.07B $60.38B 0.11%
2017-12-31 $4.80B $64.21B 7.66%
2017-09-30 $4.53B $63.85B 7.41%
2017-06-30 $4.84B $61.82B 8.10%
2017-03-31 $5.07B $60.97B 8.63%
2016-12-31 $1.91B $57.87B 3.32%
2016-09-30 $1.91B $58.32B 3.36%
2016-06-30 $2.22B $57.90B 3.95%
2016-03-31 $2.26B $56.52B 4.04%
2015-12-31 $1.96B $55.09B 3.55%
2015-09-30 $1.80B $55.82B 3.26%
2015-06-30 $1.65B $55.93B 3.04%
2015-03-31 $1.48B $53.87B 2.76%
2014-12-31 $1.71B $55.11B 3.23%
2014-09-30 $1.31B $52.23B 2.70%
2014-06-30 $1.24B $53.01B 2.80%
2014-03-31 $1.26B $51.76B 3.16%
2013-12-31 $1.15B $36.48B 3.23%
2013-09-30 $1.39B $35.95B 3.97%
2013-06-30 $1.38B $35.49B 4.04%
2013-03-31 $1.34B $34.79B 4.03%
2012-12-31 $1.60B $33.43B 4.88%
2012-09-30 $1.60B $32.97B 4.89%
2012-06-30 $1.50B $31.75B 4.61%
2012-03-31 $1.40B $33.09B 4.34%
2011-12-31 $1.30B $33.16B 4.11%
2011-09-30 $1.16B $31.91B 3.73%
2011-06-30 $1.19B $31.02B 4.00%
2011-03-31 $1.20B $30.89B 4.16%
2010-12-31 $1.13B $30.40B 4.00%
2010-09-30 $1.30B $26.79B 4.73%
2010-06-30 $1.27B $27.40B 4.64%
2010-03-31 $1.26B $28.19B 4.67%
2009-12-31 $1.20B $27.54B 4.55%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $73.526B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
West Pharmaceutical Services (WST) United States $23.683B 48.37
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
Merit Medical Systems (MMSI) United States $5.611B 28.65
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
CONMED (CNMD) United States $2.162B 18.04
STAAR Surgical (STAA) United States $1.231B 45.42
Lifevantage (LFVN) United States $0.222B 29.55
Pro-Dex (PDEX) United States $0.151B 30.10